HEADER CELL ADHESION 21-AUG-12 4GPV TITLE CRYSTAL STRUCTURE OF A PUTATIVE CELL ADHESION PROTEIN (BACEGG_00536) TITLE 2 FROM BACTEROIDES EGGERTHII DSM 20697 AT 1.67 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE CELL ADHESION PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES EGGERTHII; SOURCE 3 ORGANISM_TAXID: 483216; SOURCE 4 STRAIN: DSM 20697; SOURCE 5 GENE: BACEGG_00536; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: PB1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS MAJOR FIMBRIAL SUBUNIT PROTEIN (FIMA), PF06321 FAMILY, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-BIOLOGY, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 01-FEB-23 4GPV 1 REMARK SEQADV REVDAT 4 22-APR-20 4GPV 1 JRNL LINK REVDAT 3 24-JAN-18 4GPV 1 JRNL REVDAT 2 15-NOV-17 4GPV 1 REMARK REVDAT 1 19-SEP-12 4GPV 0 JRNL AUTH Q.XU,M.SHOJI,S.SHIBATA,M.NAITO,K.SATO,M.A.ELSLIGER, JRNL AUTH 2 J.C.GRANT,H.L.AXELROD,H.J.CHIU,C.L.FARR,L.JAROSZEWSKI, JRNL AUTH 3 M.W.KNUTH,A.M.DEACON,A.GODZIK,S.A.LESLEY,M.A.CURTIS, JRNL AUTH 4 K.NAKAYAMA,I.A.WILSON JRNL TITL A DISTINCT TYPE OF PILUS FROM THE HUMAN MICROBIOME. JRNL REF CELL V. 165 690 2016 JRNL REFN ISSN 1097-4172 JRNL PMID 27062925 JRNL DOI 10.1016/J.CELL.2016.03.016 REMARK 2 REMARK 2 RESOLUTION. 1.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.10.0 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 70657 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.161 REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 3565 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.71 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.78 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5234 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2239 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4987 REMARK 3 BIN R VALUE (WORKING SET) : 0.2238 REMARK 3 BIN FREE R VALUE : 0.2272 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.72 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 247 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4761 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 16 REMARK 3 SOLVENT ATOMS : 773 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.84 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.79450 REMARK 3 B22 (A**2) : 6.26770 REMARK 3 B33 (A**2) : 0.52680 REMARK 3 B12 (A**2) : -0.81280 REMARK 3 B13 (A**2) : -0.39550 REMARK 3 B23 (A**2) : 0.24700 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.228 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.952 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5040 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6919 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2304 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 126 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 781 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5040 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 747 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6285 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.84 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.45 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|28 - 363} REMARK 3 ORIGIN FOR THE GROUP (A): 62.5162 89.8645 -18.1665 REMARK 3 T TENSOR REMARK 3 T11: -0.0725 T22: -0.0653 REMARK 3 T33: -0.0734 T12: 0.0092 REMARK 3 T13: 0.0060 T23: 0.0053 REMARK 3 L TENSOR REMARK 3 L11: 0.9172 L22: 2.2014 REMARK 3 L33: 0.6906 L12: -0.9382 REMARK 3 L13: 0.0865 L23: 0.0861 REMARK 3 S TENSOR REMARK 3 S11: 0.0006 S12: 0.0244 S13: -0.0432 REMARK 3 S21: 0.0471 S22: -0.0236 S23: 0.0069 REMARK 3 S31: -0.0236 S32: 0.0511 S33: 0.0230 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {B|28 - 363} REMARK 3 ORIGIN FOR THE GROUP (A): 38.8535 60.9851 9.1630 REMARK 3 T TENSOR REMARK 3 T11: 0.0020 T22: -0.0796 REMARK 3 T33: -0.0679 T12: -0.0133 REMARK 3 T13: -0.0057 T23: 0.0140 REMARK 3 L TENSOR REMARK 3 L11: 0.4531 L22: 1.8329 REMARK 3 L33: 0.4205 L12: 0.4060 REMARK 3 L13: 0.0717 L23: 0.2161 REMARK 3 S TENSOR REMARK 3 S11: 0.0012 S12: 0.0025 S13: 0.0200 REMARK 3 S21: -0.0942 S22: 0.0181 S23: 0.1497 REMARK 3 S31: 0.0468 S32: 0.0419 S33: -0.0194 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 3. TRIS (TRS) MODELED ARE PRESENT IN CRYSTALLIZATION REMARK 3 CONDITIONS. 4. NCS RESTRAINTS WERE APPLIED USING BUSTER'S LSSR REMARK 3 RESTRAINT REPRESENTATION (-AUTONCS) REMARK 4 REMARK 4 4GPV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074488. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97903 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR; DOUBLE REMARK 200 CRYSTAL SI(111) MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE MARCH 15, 2012 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70659 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.670 REMARK 200 RESOLUTION RANGE LOW (A) : 40.625 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.76200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM ACETATE, 30.0% REMARK 280 POLYETHYLENE GLYCOL 4000, 0.1M TRIS HYDROCHLORIDE PH 8.5, REMARK 280 NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ASN A 21 REMARK 465 ASP A 22 REMARK 465 GLU A 23 REMARK 465 VAL A 24 REMARK 465 GLU A 25 REMARK 465 ASN A 26 REMARK 465 LEU A 27 REMARK 465 ASN A 48 REMARK 465 GLN A 49 REMARK 465 ALA A 50 REMARK 465 GLN A 51 REMARK 465 SER A 52 REMARK 465 ARG A 53 REMARK 465 ALA A 54 REMARK 465 ALA A 55 REMARK 465 GLY A 56 REMARK 465 LYS A 364 REMARK 465 GLU A 365 REMARK 465 PHE A 366 REMARK 465 ASN A 367 REMARK 465 GLY B 0 REMARK 465 ASN B 21 REMARK 465 ASP B 22 REMARK 465 GLU B 23 REMARK 465 VAL B 24 REMARK 465 GLU B 25 REMARK 465 ASN B 26 REMARK 465 LEU B 27 REMARK 465 GLN B 49 REMARK 465 ALA B 50 REMARK 465 GLN B 51 REMARK 465 SER B 52 REMARK 465 ARG B 53 REMARK 465 ALA B 54 REMARK 465 ALA B 55 REMARK 465 GLY B 56 REMARK 465 LYS B 364 REMARK 465 GLU B 365 REMARK 465 PHE B 366 REMARK 465 ASN B 367 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 47 CG OD1 OD2 REMARK 470 LYS A 147 CD CE NZ REMARK 470 ASP A 363 CG OD1 OD2 REMARK 470 ASN B 161 CG OD1 ND2 REMARK 470 ASP B 363 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 88 -151.09 -97.53 REMARK 500 ASP A 140 -4.87 73.58 REMARK 500 ASN A 231 14.27 -140.19 REMARK 500 ASP A 307 -78.49 -101.90 REMARK 500 ASP B 47 -157.97 54.58 REMARK 500 ASP B 47 -157.77 54.26 REMARK 500 SER B 88 -152.88 -98.89 REMARK 500 SER B 88 -154.39 -96.87 REMARK 500 SER B 88 -153.35 -98.27 REMARK 500 ASP B 140 -6.13 73.67 REMARK 500 ASP B 307 -79.33 -99.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: JCSG-417729 RELATED DB: TARGETTRACK REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT (21-367) WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 4GPV A 21 367 UNP B7ADR8 B7ADR8_9BACE 21 367 DBREF 4GPV B 21 367 UNP B7ADR8 B7ADR8_9BACE 21 367 SEQADV 4GPV GLY A 0 UNP B7ADR8 EXPRESSION TAG SEQADV 4GPV GLY B 0 UNP B7ADR8 EXPRESSION TAG SEQRES 1 A 348 GLY ASN ASP GLU VAL GLU ASN LEU GLY ASN ASN VAL PRO SEQRES 2 A 348 GLY GLU GLN ALA VAL LEU THR ILE LYS LEU LYS GLY ASP SEQRES 3 A 348 GLY ASP ASN GLN ALA GLN SER ARG ALA ALA GLY PRO ALA SEQRES 4 A 348 THR ASP THR GLU ASP ALA VAL ILE ASN ASN TYR LEU VAL SEQRES 5 A 348 PHE LEU PHE ARG GLU GLY GLY ALA LEU ASP CYS ALA PRO SEQRES 6 A 348 TYR GLU GLY SER SER ASN ALA ALA ALA THR ILE THR THR SEQRES 7 A 348 GLY THR THR ALA ALA LYS LYS ALA TYR VAL VAL ALA ASN SEQRES 8 A 348 THR GLY ALA LEU ALA GLY GLY LEU PHE ALA THR VAL LYS SEQRES 9 A 348 THR GLU THR ASP LEU LEU ALA VAL THR GLY SER LEU MSE SEQRES 10 A 348 ASP ASN THR ASP ASN ALA SER THR GLN THR LYS THR ASN SEQRES 11 A 348 LEU TRP MSE SER GLY GLU SER GLU VAL LYS PHE ASN GLY SEQRES 12 A 348 GLY THR ASN ALA GLN VAL THR VAL SER LEU SER PHE VAL SEQRES 13 A 348 ALA ALA LYS ILE GLN LEU ILE VAL LYS ASP ASN ARG LYS SEQRES 14 A 348 ASN MSE THR GLY GLY THR ILE THR ILE THR ASP ASP ALA SEQRES 15 A 348 ALA VAL LEU LEU PHE ALA GLY LYS LYS GLY ARG PHE PHE SEQRES 16 A 348 GLY SER ALA ALA GLU LYS VAL THR GLN ASN GLU PHE TYR SEQRES 17 A 348 THR GLY PHE ASN GLN TYR THR GLY ALA PHE ASP SER GLY SEQRES 18 A 348 VAL THR THR SER THR ALA LEU SER ASP ALA VAL SER PRO SEQRES 19 A 348 GLY ASP PHE THR ILE ASN ALA GLY SER THR VAL PHE ASN SEQRES 20 A 348 HIS PHE TYR THR PHE GLY ASN ASP GLY THR THR GLN PRO SEQRES 21 A 348 THR ILE LEU ALA ILE LYS SER THR LYS THR VAL GLY GLY SEQRES 22 A 348 THR SER SER PRO ILE PHE TYR PRO ILE LEU PHE THR ASN SEQRES 23 A 348 THR ASP ALA ARG HIS THR ILE GLU PRO GLY LYS SER TYR SEQRES 24 A 348 THR VAL THR VAL THR LEU ASN GLY ASP VAL ALA ALA GLY SEQRES 25 A 348 GLY GLY GLY GLY THR THR ASP PRO GLU GLU PRO VAL VAL SEQRES 26 A 348 SER SER SER ILE GLU VAL THR VAL THR ALA ALA GLN TRP SEQRES 27 A 348 VAL THR GLN PRO VAL ASP LYS GLU PHE ASN SEQRES 1 B 348 GLY ASN ASP GLU VAL GLU ASN LEU GLY ASN ASN VAL PRO SEQRES 2 B 348 GLY GLU GLN ALA VAL LEU THR ILE LYS LEU LYS GLY ASP SEQRES 3 B 348 GLY ASP ASN GLN ALA GLN SER ARG ALA ALA GLY PRO ALA SEQRES 4 B 348 THR ASP THR GLU ASP ALA VAL ILE ASN ASN TYR LEU VAL SEQRES 5 B 348 PHE LEU PHE ARG GLU GLY GLY ALA LEU ASP CYS ALA PRO SEQRES 6 B 348 TYR GLU GLY SER SER ASN ALA ALA ALA THR ILE THR THR SEQRES 7 B 348 GLY THR THR ALA ALA LYS LYS ALA TYR VAL VAL ALA ASN SEQRES 8 B 348 THR GLY ALA LEU ALA GLY GLY LEU PHE ALA THR VAL LYS SEQRES 9 B 348 THR GLU THR ASP LEU LEU ALA VAL THR GLY SER LEU MSE SEQRES 10 B 348 ASP ASN THR ASP ASN ALA SER THR GLN THR LYS THR ASN SEQRES 11 B 348 LEU TRP MSE SER GLY GLU SER GLU VAL LYS PHE ASN GLY SEQRES 12 B 348 GLY THR ASN ALA GLN VAL THR VAL SER LEU SER PHE VAL SEQRES 13 B 348 ALA ALA LYS ILE GLN LEU ILE VAL LYS ASP ASN ARG LYS SEQRES 14 B 348 ASN MSE THR GLY GLY THR ILE THR ILE THR ASP ASP ALA SEQRES 15 B 348 ALA VAL LEU LEU PHE ALA GLY LYS LYS GLY ARG PHE PHE SEQRES 16 B 348 GLY SER ALA ALA GLU LYS VAL THR GLN ASN GLU PHE TYR SEQRES 17 B 348 THR GLY PHE ASN GLN TYR THR GLY ALA PHE ASP SER GLY SEQRES 18 B 348 VAL THR THR SER THR ALA LEU SER ASP ALA VAL SER PRO SEQRES 19 B 348 GLY ASP PHE THR ILE ASN ALA GLY SER THR VAL PHE ASN SEQRES 20 B 348 HIS PHE TYR THR PHE GLY ASN ASP GLY THR THR GLN PRO SEQRES 21 B 348 THR ILE LEU ALA ILE LYS SER THR LYS THR VAL GLY GLY SEQRES 22 B 348 THR SER SER PRO ILE PHE TYR PRO ILE LEU PHE THR ASN SEQRES 23 B 348 THR ASP ALA ARG HIS THR ILE GLU PRO GLY LYS SER TYR SEQRES 24 B 348 THR VAL THR VAL THR LEU ASN GLY ASP VAL ALA ALA GLY SEQRES 25 B 348 GLY GLY GLY GLY THR THR ASP PRO GLU GLU PRO VAL VAL SEQRES 26 B 348 SER SER SER ILE GLU VAL THR VAL THR ALA ALA GLN TRP SEQRES 27 B 348 VAL THR GLN PRO VAL ASP LYS GLU PHE ASN MODRES 4GPV MSE A 136 MET SELENOMETHIONINE MODRES 4GPV MSE A 152 MET SELENOMETHIONINE MODRES 4GPV MSE A 190 MET SELENOMETHIONINE MODRES 4GPV MSE B 136 MET SELENOMETHIONINE MODRES 4GPV MSE B 152 MET SELENOMETHIONINE MODRES 4GPV MSE B 190 MET SELENOMETHIONINE HET MSE A 136 8 HET MSE A 152 8 HET MSE A 190 13 HET MSE B 136 8 HET MSE B 152 8 HET MSE B 190 13 HET TRS A 401 8 HET TRS B 401 8 HETNAM MSE SELENOMETHIONINE HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETSYN TRS TRIS BUFFER FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 3 TRS 2(C4 H12 N O3 1+) FORMUL 5 HOH *773(H2 O) HELIX 1 1 THR A 124 VAL A 131 1 8 HELIX 2 2 SER A 216 VAL A 221 1 6 HELIX 3 3 THR B 124 VAL B 131 1 8 HELIX 4 4 SER B 216 VAL B 221 1 6 SHEET 1 A 3 ALA A 92 ILE A 95 0 SHEET 2 A 3 VAL A 37 LYS A 43 -1 N LEU A 38 O ILE A 95 SHEET 3 A 3 ASN A 165 SER A 171 1 O VAL A 168 N THR A 39 SHEET 1 B 5 THR A 59 VAL A 65 0 SHEET 2 B 5 ILE A 348 VAL A 362 1 O GLN A 356 N ASP A 60 SHEET 3 B 5 LYS A 316 ASP A 327 -1 N THR A 323 O GLU A 349 SHEET 4 B 5 ALA A 177 LYS A 188 1 N LYS A 178 O TYR A 318 SHEET 5 B 5 ASN A 266 THR A 270 -1 O PHE A 268 N ILE A 179 SHEET 1 C 5 TYR A 85 GLY A 87 0 SHEET 2 C 5 TYR A 69 ARG A 75 -1 N TYR A 69 O GLY A 87 SHEET 3 C 5 ALA A 102 ALA A 109 -1 O LYS A 103 N PHE A 74 SHEET 4 C 5 MSE A 152 GLU A 157 -1 O MSE A 152 N ALA A 109 SHEET 5 C 5 SER A 173 PHE A 174 -1 O SER A 173 N SER A 153 SHEET 1 D 2 THR A 132 SER A 134 0 SHEET 2 D 2 LYS A 210 ARG A 212 -1 O GLY A 211 N GLY A 133 SHEET 1 E 4 SER A 248 ALA A 250 0 SHEET 2 E 4 ILE A 195 LEU A 205 -1 N ALA A 202 O ASP A 249 SHEET 3 E 4 ILE A 281 VAL A 290 -1 O ILE A 281 N LEU A 205 SHEET 4 E 4 THR A 293 LEU A 302 -1 O ILE A 297 N SER A 286 SHEET 1 F 3 ALA A 207 GLY A 208 0 SHEET 2 F 3 PHE A 226 THR A 228 -1 O TYR A 227 N ALA A 207 SHEET 3 F 3 VAL A 241 THR A 243 1 O THR A 242 N PHE A 226 SHEET 1 G 3 ALA B 92 ILE B 95 0 SHEET 2 G 3 VAL B 37 LYS B 43 -1 N LEU B 38 O ILE B 95 SHEET 3 G 3 ASN B 165 SER B 171 1 O VAL B 168 N THR B 39 SHEET 1 H 5 THR B 59 VAL B 65 0 SHEET 2 H 5 ILE B 348 VAL B 362 1 O GLN B 356 N ASP B 60 SHEET 3 H 5 LYS B 316 ASP B 327 -1 N THR B 323 O GLU B 349 SHEET 4 H 5 ALA B 177 LYS B 188 1 N LYS B 178 O TYR B 318 SHEET 5 H 5 ASN B 266 THR B 270 -1 O THR B 270 N ALA B 177 SHEET 1 I 5 TYR B 85 GLY B 87 0 SHEET 2 I 5 TYR B 69 PHE B 74 -1 N TYR B 69 O GLY B 87 SHEET 3 I 5 LYS B 104 ALA B 109 -1 O TYR B 106 N PHE B 72 SHEET 4 I 5 MSE B 152 GLU B 157 -1 O MSE B 152 N ALA B 109 SHEET 5 I 5 SER B 173 PHE B 174 -1 O SER B 173 N SER B 153 SHEET 1 J 2 THR B 132 SER B 134 0 SHEET 2 J 2 LYS B 210 ARG B 212 -1 O GLY B 211 N GLY B 133 SHEET 1 K 4 SER B 248 ALA B 250 0 SHEET 2 K 4 THR B 196 LEU B 205 -1 N ALA B 202 O ASP B 249 SHEET 3 K 4 ILE B 281 VAL B 290 -1 O ILE B 281 N LEU B 205 SHEET 4 K 4 THR B 293 LEU B 302 -1 O SER B 295 N LYS B 288 SHEET 1 L 3 ALA B 207 GLY B 208 0 SHEET 2 L 3 PHE B 226 THR B 228 -1 O TYR B 227 N ALA B 207 SHEET 3 L 3 VAL B 241 THR B 243 1 O THR B 242 N PHE B 226 LINK C LEU A 135 N MSE A 136 1555 1555 1.35 LINK C MSE A 136 N ASP A 137 1555 1555 1.34 LINK C TRP A 151 N MSE A 152 1555 1555 1.34 LINK C MSE A 152 N SER A 153 1555 1555 1.32 LINK C ASN A 189 N MSE A 190 1555 1555 1.33 LINK C MSE A 190 N THR A 191 1555 1555 1.34 LINK C LEU B 135 N MSE B 136 1555 1555 1.35 LINK C MSE B 136 N ASP B 137 1555 1555 1.35 LINK C TRP B 151 N MSE B 152 1555 1555 1.33 LINK C MSE B 152 N SER B 153 1555 1555 1.31 LINK C ASN B 189 N MSE B 190 1555 1555 1.34 LINK C MSE B 190 N THR B 191 1555 1555 1.35 SITE 1 AC1 7 ASP A 249 ASN A 266 HIS A 267 HOH A 556 SITE 2 AC1 7 HOH A 621 HOH A 667 HOH A 758 SITE 1 AC2 8 ASP B 249 ASN B 266 HIS B 267 HOH B 640 SITE 2 AC2 8 HOH B 737 HOH B 760 HOH B 761 HOH B 799 CRYST1 46.060 61.488 64.112 109.61 103.02 90.90 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021711 0.000341 0.005482 0.00000 SCALE2 0.000000 0.016265 0.006041 0.00000 SCALE3 0.000000 0.000000 0.017078 0.00000